Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes

Diabetes

Volumn 53, Issue 12, 2004, Pages 3048-3056

  Krssak, Martin ^a   Brehm, Attila ^a   Bernroider, Elisabeth ^a   Anderwald, Christian ^a   Nowotny, Peter ^a   Dalla Man, Chiara ^b   Cobelli, Claudio ^b   Cline, Gary W ^c   Shulman, Gerald I ^c   Waldhäusl, Werner ^a   Roden, Michael ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF PADOVA   (Italy)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HANUSCH HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; GLYCOGEN; INSULIN; LIPID; SOMATOSTATIN;

ADULT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLYCOGEN METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; TEST MEAL;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; LIVER GLYCOGEN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; REFERENCE VALUES;

EID: 9444262473     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.12.3048     Document Type: Article

References (55)

1. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
2. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240-246, 1999
3. Carey PE, Halliday J, Snaar JE, Morris P, Taylor R: Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol Endocrinol Metab 284:E688-E694, 2002
4. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews 5:177-269, 1997
5. Boden G, Chen X, Stein TP: Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-E30, 2001
6. Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R: Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283:E275-E283, 2002
7. Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51:3025-3032, 2002
8. Radziuk J, Pye S: Production and metabolic clearance of glucose under basal conditions in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 44:983-991, 2001
9. Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79-85, 1988
10. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA: Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus: role of hepatic and extrahepatic tissues. J Clin Invest 77:1525-1532, 1986
11. Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43:1549-1557, 1994
12. McMahon M, Marsh HM, Rizza RA: Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. Diabetes 38:291-303, 1989
13. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
14. Felig P, Wahren J, Hendler R: Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes 27:121-126, 1978
15. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA: Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351-1362, 2001
16. Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P: Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 88:2055-2060, 2003
17. Beringer A, Thaler H: [On quantitative analyses of the glycogen content of the liver in normal and sick persons.] Wien Klin Wochenschr 26:509-513, 1963
18. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI: Increased rate of gluconeogenesis in type II diabetes mellitus: a 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327, 1992
19. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063-2069, 2000
20. Cherrington AD: Banting Lecture 1997: Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214, 1999
21. Roden M, Perseghin G, Petersen KF, Hwang JH, Cline GW, Gerow K, Rothman DL, Shulman GI: The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642-648, 1996
22. Cline GW, Rothman DL, Magnusson I, Katz LD, Shulman GI: 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J Clin Invest 94:2369-2376, 1994
23. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI: Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209, 1998
24. Stingl H, Krssak M, Krebs M, Bischof MG, Nowotny P, Furnsinn C, Shulman GI, Waldhäusl W, Roden M: Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 44:48-54, 2001
25. Iozzo P, Geisler F, Oikonen V, Maki M, Takala T, Solin O, Ferrannini E, Knuuti J, Nuutila P: Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study. J Nucl Med 44:682-689, 2003
26. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758, 2000
27. Taylor R, Magnusson I, Rothman DL, Cline GW, Caumo A, Cobelli C, Shulman GI: Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97:126-132, 1996
28. Bischof MG, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman GI, Waldhäusl W, Roden M: Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes 51:49-54, 2002
29. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284:E55-E69, 2003
30. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI: Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254:573-576, 1991
31. Hwang JH, Perseghin G, Rothman DL, Cline GW, Magnusson I, Petersen KF, Shulman GI: Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion: a 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783-787, 1995
32. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, Waldhäusl W: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364, 1999
33. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhäusl W, Roden M: Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 46:950-954, 2000
34. Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI: Liver glycogen turnover in fed and fasted humans. Am J Physiol 266:E796-E803, 1994
35. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
36. Sparacino G, Pillonetto G, Capello M, De Nicolao G, Cobelli C: WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems. Comput Methods Programs Biomed 67:67-77, 2002
37. Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E, Waldhäusl W, Roden M: Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51: 599-605, 2002
38. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755-1761, 1996
39. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA: Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272-283, 2000
40. Cobelli C, Mari A, Ferrannini E: Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol 252:E679-E689, 1987
41. Waldhäusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P: Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23:6-15, 1982
42. Boden G, Chen X, Capulong E, Mozzoli M: Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50:810-816, 2001
43. Waldhäusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P: Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17:221-227, 1979
44. Bjorkman O, Eriksson LS, Nyberg B, Wahren J: Gut exchange of glucose and lactate in basal state and after oral glucose ingestion in postoperative patients. Diabetes 39:747-751, 1990
45. Unger RH: Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27:1691-1709, 1978
46. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA: Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab 285:E25-E30, 2003
47. Hother-Nielsen O, Vaag A, Skott P, Beck-Nielsen H: Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42:86-93, 1993
48. Landau BR: Methods for measuring glycogen cycling. Am J Physiol Endocrinol Metab 281:E413-E419, 2001
49. Matsuda M, Defronzo RA, Glass L, Consoli A, Giordano M, Bressler P, Delprato S: Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism 51:1111-1119, 2002
50. Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA: Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis. Diabetes 46:2007-2016, 1997
51. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF: The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797-802, 2002
52. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142, 2003
53. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028, 2002
54. Tiikkainen M, Tamminen M, Hakkinen AM, Bergholm R, Vehkavaara S, Halavaara J, Teramo K, Rissanen A, Yki-Jarvinen H: Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859-867, 2002
55. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850, 2001